C14orf1_0610007P14Rik Inhibitors
C14orf1_0610007P14Rik Inhibitors are chemical compounds that interfere with the functional activity of the C14orf1_0610007P14Rik protein by affecting specific signaling pathways or biological processes in which it is directly involved. For instance, Staurosporine and Genistein are potent inhibitors of protein kinases, including PKC and tyrosine kinases respectively, which are key regulators of cell proliferation and survival. By inhibiting these kinases, these compounds can hinder corresponding signaling pathways and decrease the functional activity of C14orf1_0610007P14Rik. Similarly, Wortmannin and LY294002 are potent inhibitors of PI3K, a kinase involved in many cellular functions including cell growth and proliferation. Byinhibiting PI3K, these compounds can disrupt these processes, leading to decreased functional activity of C14orf1_0610007P14Rik.
In addition, some inhibitors like PD98059, U0126, and SB203580 target the MAPK/ERK pathway, which is also involved in cell proliferation and survival. Inhibition of this pathway by these compounds can decrease the functional activity of C14orf1_0610007P14Rik. On the other hand, SP600125 and Y-27632 are selective inhibitors of JNK and ROCK respectively. JNK is a key regulator of apoptosis, and ROCK is involved in cell motility. Inhibition of these kinases could lead to decreased functional activity of C14orf1_0610007P14Rik. Lastly, Rapamycin is an mTOR inhibitor, which is involved in protein synthesis and cell growth, and PD173074 is a potent inhibitor of FGFR tyrosine kinase, involved in cell growth and differentiation. Inhibition of these pathways can also lead to decreased functional activity of C14orf1_0610007P14Rik.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases, including PKC, which plays a key role in the regulation of cell proliferation and survival. By inhibiting PKC, Staurosporine can hinder the corresponding signaling pathways and decrease the functional activity of C14orf1_0610007P14Rik, which is involved in these pathways. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin is a potent and irreversible inhibitor of PI3K. PI3K is involved in many cellular functions including cell growth and proliferation. By inhibiting PI3K, Wortmannin could disrupt these processes, leading to decreased functional activity of C14orf1_0610007P14Rik. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059 is a MEK inhibitor that blocks the MAPK/ERK pathway, which is involved in cell proliferation and survival. By inhibiting this pathway, PD98059 can decrease the functional activity of C14orf1_0610007P14Rik. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a selective inhibitor of JNK, a key regulator of apoptosis. By inhibiting JNK, SP600125 could lead to decreased functional activity of C14orf1_0610007P14Rik, which is involved in the JNK signaling pathway. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
Y-27632 is a selective inhibitor of ROCK, a kinase involved in cell motility. By inhibiting ROCK, Y-27632 can lead to decreased functional activity of C14orf1_0610007P14Rik, which is involved in the ROCK signaling pathway. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is a potent inhibitor of PI3K, a kinase involved in cell survival and proliferation. By inhibiting PI3K, LY294002 can lead to decreased functional activity of C14orf1_0610007P14Rik. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580 is a specific inhibitor of p38 MAPK, involved in inflammation and cell differentiation. Inhibition of p38 MAPK by SB203580 could lead to decreased functional activity of C14orf1_0610007P14Rik. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Genistein is a potent inhibitor of protein tyrosine kinases, which are involved in cell signaling. By inhibiting these kinases, Genistein can decrease the functional activity of C14orf1_0610007P14Rik. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $92.00 $223.00 | 30 | |
PP2 is a selective inhibitor of Src family kinases. Src kinases are involved in many cellular processes including proliferation, differentiation, and survival. By inhibiting Src kinases, PP2 can decrease the functional activity of C14orf1_0610007P14Rik. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin is an mTOR inhibitor, involved in protein synthesis and cell growth. By inhibiting mTOR, Rapamycin can decrease the functional activity of C14orf1_0610007P14Rik. | ||||||